Nicholas A.j. Botwood - 16 May 2025 Form 4 Insider Report for Syndax Pharmaceuticals Inc (SNDX)

Signature
/s/ Michael A. Metzger, Attorney-in-Fact
Issuer symbol
SNDX
Transactions as of
16 May 2025
Net transactions value
+$105,826
Form type
4
Filing time
19 May 2025, 16:03:03 UTC
Previous filing
16 May 2025
Next filing
06 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Botwood Nicholas A.J. Head of R&D, CMO 730 THIRD AVENUE, FLOOR 9, NEW YORK /s/ Michael A. Metzger, Attorney-in-Fact 19 May 2025 0002066784

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNDX Common Stock Purchase $105,826 +11,765 +50% $9.00 35,165 16 May 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.